You are here

  • Home
  • Archive
  • Volume 74, Issue 6
  • Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17

Citation Tools

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Lightman S, Taylor SRJ, Bunce C, et al
Pegylated interferon-α-2b reduces corticosteroid requirement in patients with Behçet's disease with upregulation of circulating regulatory T cells and reduction of Th17
Annals of the Rheumatic Diseases 2015;74:1138-1144.